+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latin America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Fertility, Cardiac Markers, Hematology) By End-use, By Country, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 96 Pages
  • September 2023
  • Region: Latin America
  • Grand View Research
  • ID: 5893228

The Latin America point of care diagnostics Market size is expected to reach USD 5.9 billion, expanding at a CAGR of 7.3% by 2030. Penetration of major key players in Latin American countries coupled with increased initiatives by government and academic institutes towards retaining the spread of chronic diseases is expected to fuel market growth through to 2024.



Moreover, the increased density of geriatric population in the countries and the immigration of retired people from Northern and Central America to this region looking forward towards assisted living healthcare and home health care is anticipated to propel growth in the coming years. Furthermore, owing to the increased geriatric population prevalence of chronic, endemic and infectious diseases is high in LAC which is expected to increase the market potential through to 2024.

Latin America Point of Care Diagnostics Market Report Highlights

  • The infectious diseases testing kits segment accounted for the largest revenue share in 2022. Latin America has a high prevalence of infectious diseases, such as HIV/AIDS, malaria, dengue fever, and Zika virus.
  • Hb1Ac POC test is the second highest contributor to the market share with respect to revenue. This segment is expected to grow at a CAGR faster than glucose testing owing to its reliability and rapidly increased patient base for diabetes management.
  • The high prevalence of endemic infectious disease along with positive potential for emergence of new diseases like Ebola make infectious disease testing another segment of prime activity in Latin America point of care market. This segment includes rapid diagnostic tests for a considerable number of infectious diseases like HIV, Influenza/Flu, Clostridium Difficile, HBV, HPV, Pneumonia Or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV), HCV, MRSA, TB And Drug-Resistant TB, HSV, Ebola, Cryptosporidiosis, E.Histolytica, Syphilis, Legionella/Legionnaires’ Disease, Adenovirus Infections, Trichomonas, Rubella
  • The growing prevalence of a number of infectious diseases in lower economy countries like Haiti, Bolivia, Guatemala, and others in addition to the rapid spread of STDs in developing economies of Brazil, Mexico, and Chile is expected to propel the need for POC diagnostics over the forecast period. Further, the number of initiatives by the government for early screening and diagnosis of diseases, and support to set up health checkups and camps is anticipated to contribute towards rise in demand.
  • Clinics are estimated to dominate the Latin America POC diagnostics industry with respect to end user owing to the increased awareness for health care among the population and initiatives by international healthcare organizations and number of governments to control the spread of diseases in this region. Owing to the increased availability of products and comparative rise in usage rate for disease monitoring and diagnosis the segment is expected to generate lucrative revenue for the market.
  • Brazil dominated the Latin America point of care diagnostics market and accounted for the largest revenue share of 40.8% in 2022 and is expected to witness the fastest CAGR of 7.9% over the forecast period. The presence of healthcare reforms like Unified Health System (SUS) is expected to fuel the market growth in Brazil. high prevalence of infections and rapid increase in incidences of diabetes, cancer and cardiac disorders in the country is anticipated to rise demand for POC diagnostics.
  • Mexico is expected to grow at a significant CAGR of 7.8% over the forecast period due to a large population base. This large population provides a large potential market for PoC diagnostics.
  • Strategies by participants to maintain competitive advantage over others in the industry to enhance the market presence is expected to enhance market growth in this region. Initiatives by government to bring together manufacturers, healthcare service providers and research institutes are anticipated to maintain revenue generation for the industry.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. Latin America Point Of Care Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Latin America Point Of Care Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Latin America Point Of Care Diagnostics: Product Estimates & Trend Analysis
4.1. Latin America Point Of Care Diagnostics Market: Key Takeaways
4.2. Latin America Point Of Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Glucose Testing
4.3.1. Glucose testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Hb1Ac Testing
4.4.1. Hb1Ac testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Coagulation
4.5.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Fertility/Pregnancy
4.6.1. Fertility/pregnancy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Infectious Diseases
4.7.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Cardiac Markers
4.8.1. Cardiac markers market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Thyroid Stimulating Hormone
4.9.1. Thyroid stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Hematology
4.10.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Primary Care Systems
4.11.1. Primary care systems market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Decentralized Clinical Chemistry
4.12.1. Decentralized clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Feces
4.13.1. Feces market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Lipid Testing
4.14.1. Lipid testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. Cancer Marker
4.15.1. Cancer marker market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Blood Gas/Electrolytes
4.16.1. Blood gas/electrolytes market estimates and forecasts, 2018 to 2030 (USD Million)
4.17. Ambulatory Chemistry
4.17.1. Ambulatory chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.18. Drug Abuse Testing
4.18.1. Drug abuse testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.19. Autoimmune Disease
4.19.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.20. Urinalysis/Nephrology
4.20.1. Urinalysis/nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Latin America Point Of Care Diagnostics: End-use Estimates & Trend Analysis
5.1. Latin America Point Of Care Diagnostics Market: Key Takeaways
5.2. Latin America Point Of Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Clinics
5.3.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Home
5.5.1. Home market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Assisted Living Healthcare Facilities
5.6.1. Assisted living healthcare facilities market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Laboratory
5.7.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Latin America Point Of Care Diagnostics Market: Country Estimates & Trend Analysis
6.1. Country Outlook
6.2. Latin America Point Of Care Diagnostics Market by Country: Key Takeaways
6.3. Latin America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. Brazil
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Mexico
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.4. Argentina
6.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)’
6.3.5. Rest of LA
6.3.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbott Laboratories
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Alere Inc (Abbott)
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Roche Diagnostics
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Bio-Rad Laboratories
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Danaher Corporation
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. bioMérieux
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Agilent Technologies, Inc.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. OraSure Technologies Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Siemens Healthineers
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Abaxis Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 Latin America point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 Latin America point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 4 Latin America point of care diagnostics market, by country, 2018 - 2030 (USD Million)
Table 5 Brazil point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 6 Brazil point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 7 Mexico point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 Mexico point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 Argentina point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 Argentina point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Rest of LA point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 12 Rest of LA point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Latin America point of care diagnostics: Market outlook
Fig. 9 Latin America point of care diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Latin America point of care diagnostics market driver impact
Fig. 15 Latin America point of care diagnostics market restraint impact
Fig. 16 Latin America point of care diagnostics market strategic initiatives analysis
Fig. 17 Latin America point of care diagnostics market: Product movement analysis
Fig. 18 Latin America point of care diagnostics market: Product outlook and key takeaways
Fig. 19 Glucose testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Hb1Ac testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Fertility/pregnancy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cardiac markers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Thyroid stimulating hormone market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Primary care systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Decentralized clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Feces market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Lipid testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Cancer marker market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Blood gas/electrolytes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Ambulatory chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Drug abuse testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Autoimmune disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Urinalysis/nephrology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Latin America point of care diagnostics market: End-use movement analysis
Fig. 38 Latin America point of care diagnostics market: End-use outlook and key takeaways
Fig. 39 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Home market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Assisted living healthcare facilities market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Laboratory market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Latin America point of care diagnostics market: Country movement analysis
Fig. 45 Latin America point of care diagnostics market: Country outlook and key takeaways
Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Rest of LA market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Abbott Laboratories
  • Alere Inc (Abbott)
  • Roche Diagnostics
  • Bio-Rad Laboratories
  • Danaher Corporation
  • bioMérieux
  • Agilent Technologies, Inc.
  • OraSure Technologies Inc
  • Siemens Healthineers
  • Abaxis Inc.

Methodology

Loading
LOADING...

Table Information